About Premature Ejaculation
Premature ejaculation (PE) is a distressing condition in which men ejaculate too quickly before or shortly after vaginal penetration (often within less than a minute).
PE Stats at a Glance
The International Society of Sexual Medicine (ISSM) recognises four subtypes of PE:
Lifelong PE: characterized by PE symptoms present since first sexual intercours
Acquired PE: characterized by PE symptoms beginning after a period of normal ejaculatory function
Natural variable PE: characterized by short ejaculatory latency which occurs irregularly and inconsistently with some subjective sense of diminished control of ejaculation
Subjective PE: characterized by one or more of the following:
1. subjective perception of consistent or inconsistent short intravaginal ejaculation latency time (IELT);
2. preoccupation with an imagined short ejaculatory latency or lack of control over the timing of ejaculation;
3. actual IELT in the normal range or even of longer duration (i.e. an ejaculation that occurs after 5 minutes);
4. ability to control ejaculation (i.e. to withhold ejaculation at the moment of imminent ejaculation) that may be diminished or lacking and;
5. the preoccupation that is not better accounted for by another mental disorder.
Incidence of PE
Lifelong and acquired PE affect around 7% of men globally
In addition to lower levels of sexual functioning and satisfaction, up to 65% of sufferers report secondary effects including decreased self-esteem, decreased sexual confidence and increased personal distress, as well as links to anxiety and depression
PE can also impact relationships with sexually dysfunctional men, including those with PE, scoring lower than sexually functional men on all measures of intimacy on the Psychological and Interpersonal Relationship Scale
"Partners of these men also suffer, and report sexual dissatisfaction and frustration, as well as problems in the relationship."
Dr Andrea Burri, Psycho-sexologist
Treatment of PE
To date, there are no FDA approved treatments for PE.
Kanna Health is developing new therapeutics in this area.
Licensed (not US) off-label oral treatments and licensed (not US) off-label topical treatments
Psychosexual counselling, education and behavioural treatments
A combination of drug and non-drug treatment